Alzheimer disease: protective factors
- PMID: 10681273
- DOI: 10.1093/ajcn/71.2.643s
Alzheimer disease: protective factors
Abstract
Approximately 6-8% of all persons aged >65 y have Alzheimer disease and the prevalence of the disease is increasing. Any intervention strategy aimed at decreasing risks or delaying the onset of the disease will therefore have a substantial effect on health care costs. Nutrition seems to be one of the factors that may play a protective role in Alzheimer disease. Many studies suggest that oxidative stress and the accumulation of free radicals are involved in the pathophysiology of the disease. Several studies have shown the existence of a correlation between cognitive skills and the serum concentrations of folate, vitamin B-12, vitamin B-6, and, more recently, homocysteine. However, nutritional factors have to be studied not alone but with the other factors related to Alzheimer disease: genetics, estrogen, antiinflammatory drug use, and socioeconomic variables. The objective of this article was to review recent studies in this field.
Comment in
-
Homocysteine and B vitamins in dementia.Am J Clin Nutr. 2001 Jan;73(1):127-8. doi: 10.1093/ajcn/73.1.127. Am J Clin Nutr. 2001. PMID: 11124762 No abstract available.
Similar articles
-
[Alzheimer disease, memory and estrogen].Rev Neurol (Paris). 2010 Apr;166(4):377-88. doi: 10.1016/j.neurol.2009.07.010. Rev Neurol (Paris). 2010. PMID: 19836813 Review. French.
-
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.JAMA. 2008 Oct 15;300(15):1774-83. doi: 10.1001/jama.300.15.1774. JAMA. 2008. PMID: 18854539 Free PMC article. Clinical Trial.
-
Estrogen replacement therapy for cognitive benefits: viable treatment or forgettable "senior moment"?Heart Dis. 2002 Jan-Feb;4(1):26-32. doi: 10.1097/00132580-200201000-00005. Heart Dis. 2002. PMID: 11975829 Review.
-
Oestrogen replacement therapy and Alzheimer's disease.Br J Obstet Gynaecol. 1996 May;103 Suppl 13:80-6. Br J Obstet Gynaecol. 1996. PMID: 8624348 Review. No abstract available.
-
More evidence links NSAID, estrogen use with reduced Alzheimer risk.JAMA. 1996 May 8;275(18):1389-90. JAMA. 1996. PMID: 8618349 No abstract available.
Cited by
-
Healthy dietary intake moderates the effects of age on brain iron concentration and working memory performance.Neurobiol Aging. 2021 Oct;106:183-196. doi: 10.1016/j.neurobiolaging.2021.06.016. Epub 2021 Jun 22. Neurobiol Aging. 2021. PMID: 34284261 Free PMC article.
-
Diet induces hepatocyte protection in fatty liver disease via modulation of PTEN signaling.Biomed Rep. 2020 Jun;12(6):295-302. doi: 10.3892/br.2020.1299. Epub 2020 Apr 22. Biomed Rep. 2020. PMID: 32382414 Free PMC article.
-
Safranal protects against beta-amyloid peptide-induced cell toxicity in PC12 cells via MAPK and PI3 K pathways.Metab Brain Dis. 2019 Feb;34(1):165-172. doi: 10.1007/s11011-018-0329-9. Epub 2018 Nov 6. Metab Brain Dis. 2019. PMID: 30402809
-
Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.PLoS One. 2016 Dec 20;11(12):e0168106. doi: 10.1371/journal.pone.0168106. eCollection 2016. PLoS One. 2016. PMID: 27997574 Free PMC article.
-
Midlife mental distress and risk for dementia up to 27 years later: the Nord-Trøndelag Health Study (HUNT) in linkage with a dementia registry in Norway.BMC Geriatr. 2015 Mar 10;15:23. doi: 10.1186/s12877-015-0020-5. BMC Geriatr. 2015. PMID: 25886723 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical